What We're Learning From Oregon's Psilocybin Experiment

A new study published in JAMA Network Open offers encouraging evidence about what can happen when psilocybin is provided in a regulated, supervised setting.

Researchers followed 346 adults who participated in Oregon's state-regulated psilocybin program, making this one of the first prospective studies to examine how people actually fare after receiving psilocybin services outside of a traditional clinical trial.

The results are promising: participants reported meaningful improvements in depression, anxiety, PTSD symptoms, overall well-being, and life satisfaction, along with high satisfaction with their experiences. Serious adverse reactions were uncommon—just 4 out of 346 participants experienced significant psychological or behavioral difficulties requiring medical attention. All four were new to psychedelics and had preexisting mental health symptoms, highlighting the importance of careful screening and support.

Encouraging Real-World Results From Oregon's Psilocybin Program

Oregon's psilocybin program is different from simply taking a psychedelic on your own. Participants receive preparation with a licensed facilitator, take psilocybin at a licensed service center under supervision, and can participate in follow-up integration sessions.

The numbers tell a compelling story about how participants experienced the program. One month after their session, 92% said they benefited from the experience, nearly 90% reported feeling safe during it, and more than 80% said it helped them meet their goals. For many, the experience was also deeply meaningful: 59% ranked it among the 10 most meaningful experiences of their lives.

Perhaps most striking were the changes in mental-health symptoms.

At the beginning of the study, 42% of participants had moderate-to-severe depression symptoms. Three months later, that figure had fallen to 17%. Moderate-to-severe anxiety dropped from 45% to 13%, while moderate-to-severe PTSD symptoms declined from 48% to 17%.

These findings are especially interesting because many participants weren't necessarily seeking psilocybin exclusively as a treatment for a diagnosed psychiatric disorder. People came for a variety of reasons, including curiosity, personal growth, trauma processing, and improving their mental health.

Looking Ahead: The Future of Regulated Psilocybin Services

As psychedelic services continue to develop, research like this can help identify what works, where the risks are, and how programs can become safer and more effective.

For a field that is still relatively young, that's genuinely good news. There's still much to learn, but this study offers an encouraging glimpse of what regulated psilocybin services could look like as they continue to evolve—combining meaningful experiences and potential mental-health benefits with the structure and safeguards needed to help people navigate them safely.

Source: Korthuis PT, Cook RR, Gregoire D, et al. Safety and Mental Health Outcomes of Oregon State-Regulated Psilocybin Services. JAMA Netw Open. 2026;9(8):e2630608. doi:10.1001/jamanetworkopen.2026.30608